Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10023570 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Patent 10023570 was granted and assigned to Array Biopharma Inc. on July, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Array Biopharma Inc.

Current Assignee

Array Biopharma Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

100235700

Patent Inventor Names

Steven W. Andrews0

Adam Golos0

Gabrielle R. Kolakowski0

James F. Blake0

Julia Haas0

Mark J. Chicarelli0

Yutong Jiang0

Date of Patent

July 17, 2018

Patent Application Number

152117020

Date Filed

July 15, 2016

Patent Citations Received

‌

US Patent 11964988 Fused heterocyclic compounds as RET kinase inhibitors

‌

US Patent 11524963 Substituted pyrazolo[3,4-d]pyrimidines as RET kinase inhibitors

‌

US Patent 11603374 Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors

‌

US Patent 11851434 Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors

‌

US Patent 11472802 Substituted pyrazolyl[4,3-c]pyridine compounds as RET kinase inhibitors

Patent Primary Examiner

‌

Deepak R Rao

Patent abstract

Provided herein are compounds of the General Formula I:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10023570 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API